Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR-Reference-Cited by-同舟云学术

Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR

Published:2004-07 Issue:7 Volume:59 Page:709-717
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Vignola A. M.,Humbert M.,Bousquet J.,Boulet L-P.,Hedgecock S.,Blogg M.,Fox H.,Surrey K.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1398-9995.2004.00550.x/fullpdf

Reference39 articles.

1. Allergic rhinitis in Rochester, Minnesota residents with asthma: Frequency and impact on health care charges

2. Epidemiologic evidence for asthma and rhinitis comorbidity

3. Rhinitis and asthma: Evidence for respiratory system integration

4. Links between rhinitis and asthma

5. Serum immunoglobulin E levels predict human airway reactivity in vitro

Cited by 330 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rhinoconjunctivitis severity induced by cat exposure influences early and late asthmatic responses: Evidence from an environmental exposure chamber;Clinical & Experimental Allergy;2024-04-25

2. Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials;European Respiratory Review;2024-04-24

3. The Incredible Adventure of Omalizumab;International Journal of Molecular Sciences;2024-03-06

4. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma;American Journal of Respiratory and Critical Care Medicine;2024-02-01

5. A Randomized, Single‐Dose, Parallel‐Controlled Phase I Clinical Comparison of an Omalizumab Biosimilar Candidate with Reference Omalizumab in Healthy Chinese Male Volunteers;Clinical Pharmacology in Drug Development;2023-12-06